Kingworld Medicines Launches Nin Jiom Lingzhi Mel

To Meet Different Customer Needs

HONG KONG, Dec. 7, 2011 /PRNewswire-Asia/ -- Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Company" and, together with its subsidiaries, the "Group", Stock code: 01110), a distributor of renowned branded imported pharmaceutical and healthcare products in the PRC, announced that it began to sell its new product Nin Jiom Lingzhi Mel under leading cough medicine brand Nin Jiom at the end of November after the Group's collaboration with the Walt Disney Company to launch adhesive bandages, a new type of "Cool Stickers".

Nin Jiom Pei Pa Koa ranks top in PRC cough relieving product market

Nin Jiom Pei Pa Koa has the largest market share in the PRC cough relieving products and is the best-selling product of Kingworld Medicines. The renowned Nin Jiom trademark is widely recognized for its high quality and reasonable prices. Since Kingworld Medicines started to distribute Nin Jiom Pei Pa Koa in 1997, the product has ranked top in the PRC cough relieving product market with more than 10 years of development. In the first half of 2011, the Group recorded a greater year-on-year increase in sales of Nin Jiom Pei Pa Koa compared to its peers.

Kingword Medicines launches Nin Jiom Lingzhi Mel

As the global aging problem is becoming more rapidly and the public awareness of health has been increasing in recent years, the size of China's healthcare product market has surpassed that of Japan to become the second-largest in the world with RMB91.1 billion sales and a 31.57% CAGR in the past three years. Moreover, as the "back to nature" concept is getting popular and consumers prefer natural healthcare products, this segment shows enormous potential. In this light, Nin Jiom developed the new Nin Jiom Lingzhi Mel. Nin Jiom Medicine has over 60 years of experience in the development of proprietary Chinese medicine. Nin Jiom Lingzhi Mel has a mild formula enriched with Chinese medicine extracts including ganoderma lucidum, panax ginseng, chrysanthemum and polygonatum odoratum.

Nin Jiom Medicine is stringent in the selection of natural Chinese medicine from its base established at the Tibetan Plateau. It has also applied high standards to its production and adopted special techniques in the manufacturing of Nin Jiom Lingzhi Mel so that its healthcare ingredients are easily absorbed to boost human immunity. Approved by the State Food and Drug Administration, the product was launched in China at the end of November.

Nin Jiom Lingzhi Mel targets the mid-to-high end market. Leveraging on Nin Jiom's brand awareness and product quality established over years as well as Kingworld Medicines' strong network and marketing efforts, Nin Jiom Lingzhi Mel is expected to gain a position in the market.

About Kingworld Medicines Group Limited

Kingworld Medicines Group Limited is principally engaged in the distribution of branded imported pharmaceutical and healthcare products in the PRC. The Group ranked among the top 100 importers of its kind in China in 2010 based on imported value. The Group managed a portfolio of 60 products under 10 different functional categories which are manufactured in Japan, Canada, Hong Kong, Taiwan, Thailand and the PRC and sourced from 13 different suppliers. Many of which are established brand names including Nin Jiom Pei Pa Koa, Taiko Seirogan, Kawai Liver Oil Drop series, Flying Eagle Wood Lok Medicated Oil, Imada Red Flower Oil, Kyushin Pill and Mentholatum series.

For enquiries, please contact:

Porda Havas International Finance Communications Group

Fax: +852-3150-6728